Key result
Catheter ablation may mitigate cardiovascular morbidity and mortality in high-burden AF.
Why the study?
Advances in cardiac monitoring allow quantification of atrial fibrillation burden, warranting a summary of its link to adverse outcomes and the role of catheter ablation.
Does catheter ablation reduce adverse cardiovascular and cerebrovascular outcomes in patients with atrial fibrillation?
Does catheter ablation reduce adverse cardiovascular and cerebrovascular outcomes in patients with atrial fibrillation?
Catheter ablation may play a role in mitigating the morbidity and mortality associated with a greater burden of atrial fibrillation.
May guide ablation decisions for high AF burden; leaves open confirmation of outcome reduction in RCTs.
Atrial fibrillation is the most common atrial arrhythmia and accounts for a significant burden of cardiovascular disease globally. With advances in implanted and wearable cardiac monitoring technology, it is now possible to readily and accurately quantify an individual’s time spent in atrial fibrillation. This review summarizes the relationship between atrial fibrillation burden and adverse cardiovascular and cerebrovascular outcomes and discusses the role of catheter ablation to mitigate the morbidity and mortality associated with greater burden of atrial fibrillation.
No takes yet. Share an insight, caveat, or question.
Its licence doesn't allow us to show a copy here.
Schwennesen et al. (2023) conducted a review in Atrial fibrillation. Catheter ablation was evaluated on Adverse cardiovascular and cerebrovascular outcomes. Catheter ablation is discussed as a strategy to mitigate the morbidity and mortality associated with a greater burden of atrial fibrillation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: